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Biocatalysis, the use of enzymes in chemical transformations, is an important green chemistry tool. 
Cascade reactions combine different enzyme activities in a sequential set of reactions. Cascades can 
occur within a living (usually bacterial) cell; in vitro in ‘one pot’ systems where the desired enzymes 
are mixed together to carry out the multi-enzyme reaction; or using microfluidic systems. 
Microfluidics offers particular advantages when the product of the reaction inhibits the enzyme(s). 
In vitro systems allow variation of different enzyme concentrations to optimise the metabolic ‘flux’, 
and the addition of enzyme cofactors as required. Cascades including cofactor recycling systems and 
modelling approaches are being developed to optimise cascades for wider industrial scale use. Two 
industrially important enzymes, transaminases and carboxylic acid reductases are used as examples 
regarding their applications in cascade reactions with other enzyme classes to obtain important 
synthons of pharmaceutical interest.  
 
Highlights 
 Enzyme cascades represent an extension of biocatalysis to multiple reactions.  
 Combining cascades allows cofactor regeneration and drives reactions to completion.  
 Cascade modelling offers opportunities for optimisation and greater yields.  
 Transaminase and carboxylic acid reductase based cascades are powerful examples of these 
principles. 
 














1. Introduction  
Biocatalysis is the enzymatic transformation of chemical substrates into a target product molecule . 
The metabolic enzymes and secondary metabolism of microorganisms have been exploited for food 
and beverage preparation for thousands of years. During the 20th century, whole cells and cell 
extracts were used to perform reactions previously synthesised by organic chemistry [1, 2]. The 
increasing use of purified or semi-purified enzymes and whole cells in these reactions has been 
driven by the developments of DNA sequencing, bioinformatics, gene synthesis, molecular biology 
techniques, and highly sensitive analytical techniques [1, 3].  Applications for bulk enzymes include 
cleaning products, the food and leather industries, bioremediation and biofuels. Biocatalysis is well 
suited to production of high value chiral compounds for cosmetics, fine chemicals and 
pharmaceuticals [4, 5]. The use of enzymes is expected to grow significantly with the drive to a more 
sustainable society and ‘circular economy’.   
The development of sustainable or ‘green’ chemical manufacturing is in increasing demand  [6-9]. 
Public concerns and regulatory pressure for the reduction in the use of metal catalysts and reduced 
generation of hazardous waste substances will drive further development of biocatalysts [10]. This 
includes their use in recycling and minimising waste and energy use. Traditional organic syntheses 
generally require many successive reactions. Each reaction requires tightly defined, empirically 
determined conditions (temperature, pH, solvents, catalysts, substrates, etc.) to achieve a high yield. 
After each stage, unreacted substrates and side products must be removed [11]. These syntheses 
often therefore require the purification of the intermediates at each stage , which can produce 
further waste. The succession of reactions and purification reduces both atom economy and yield, 
and generates a plethora of wastes including toxic materials such as metals and organic solvents.  
Semi-synthetic methods utilize chemicals derived from microbial, plant and/or animal sources. The 
availability of these chemicals is often dependent on the growth rate of the specific organism and 
often provides low yields, leading to unsustainable batch production. Recycling and sustainability are 
key aspects of the ‘circular economy’. Consequently, biological methods and chemical-biological 
pathways are becoming the choice to develop new ‘green’ chemical processes within industry  [3].  
Enzymes are ideally suited to overcome many of the challenges within synthetic or semi -synthetic 
chemistry [12, 13]. They typically display high enantio- and regioselectivity which is essential for the 
pharmaceutical industries [13]. Using enzymes reduces the number of steps required and eliminates 
the need for protection and de-protection of functional groups. Enzymes are rarely toxic or 
dangerous, and usually work in aqueous solution under mild reaction conditions. The principles 
underpinning single enzyme biotransformations can be extended to cascades of multiple enzymes, 













companies such as Ginkgo Bioworks, GlaxoSmithKline and Evolva were early developers of enzymatic 
cascades. These cascades are being used to synthesise fragrances [14], medicinal compounds [15]  
and flavourings [16, 17].  
 
2. Cascade reactions  
2.1 Uses and categorisation of cascade reactions 
Enzyme cascades typically concatenate several natural functionalities into an enhanced natural 
pathway or non-natural pathway (i.e. using promiscuous enzymes from diverse sources to transform 
chemicals not found in nature). This allows the production of chemical commodities through 
biotransformation, or phenotype generation within cell -based systems [8]. The reactions can be 
carried out in in vivo or in vitro (reviewed by [18]). Performing reactions in vivo eliminates the need 
for the addition of expensive cofactors. However, reaction intermediates can be toxic to the cell, 
product recovery can be more demanding, and additional side reactions often occur reducing the 
yield. An additional challenge is management of the metabolic flux (i.e. the passage of a metabolite 
through the reaction system over time) [19]. In vivo, unexpected metabolic bottlenecks, or toxic 
effects of intermediates, can require rebalancing of the pathway to optimise metabolite 
concentrations. This requires a pathway engineering approach to identify rate-controlling steps and 
re-optimise enzyme concentrations by changing promoters or/and ribosome binding sites (RBS) [20-
22]. In vitro reactions use either crude lysates or enzymes that have been partially or highly purified. 
They can be carried out as ‘one pot’ reactions or with flow immobilised enzymes in tandem flow 
bioreactors [23-25]. The latter approach allows for the flux issues to be addressed since the enzyme 
concentrations used can be varied and product inhibition is avoided. ‘One pot’ reactions can be 
configured so that enzymes work simultaneously, catalysts can be added sequentially at different 
time points, or spontaneous reactions can be initiated by an enzymatic biotransformation and 
continue without further catalysis [26, 27]. Many examples of ‘one pot’ reactions have been 
reported in the literature such as the regio- and stereoselective synthesis of chiral amines (reviewed 
by [28]).  
One-pot multi-enzymatic or chemoenzymatic reaction cascades can typically be classified into one of 
five types (linear, orthogonal, parallel, triangular and cyclical cascades as shown in Figure 1) [15, 29]. 
Linear cascades are the simplest cascade form [30]. They involve a linear sequence of 
biotransformations processing a single substrate into a single product via one or more 













processing of unstable or toxic intermediates, with an example in [23]. Orthogonal cascades, in 
contrast, consist of a single transformation that is coupled to auxiliary reactions to promote the 
formation of the desired product. Orthogonal cascades achieve this in diverse ways. A very common 
approach is the removal of unwanted co-products or regeneration of cofactors and/ or co-substrates 
(to drive equilibria towards the desired product; e.g. [31, 32]). Cofactor regeneration may also be 
achieved by using a parallel cascade. Whilst orthogonal cascades couple with one or more irrelevant 
auxiliary reactions, parallel cascades incorporate a second potentially useful reaction with a 
reciprocal demand for cofactor turnover (elegantly demonstrated for NADP+ and pyridoxal 
phosphate regeneration in [33]).  Cyclical cascades and triangular cascades are the least common 
forms of cascade, due to their specialized applications. Cyclic cascades require recycling of some 
intermediates to the starting materials, for example in deracemization reactions. An excellent recent 
example of this is the deracemization of tetrahydroisoquinolines [34]. This one-pot enzymatic 
cascade improved on a previously described chemoenzymatic reaction [35]. Triangular cascades 
involve the conversion of an initial substrate to an intermediate that then combines with the ini tial 
substrate in a later step (with an example in [36]).  
The classification of enzyme cascades using the above designs affords the most basic representation 
of potential processes. Cascade design may involve combinatorial versions of these cascades giving 
rise to interesting properties and advantages. For example, a cyclical regeneration system may be 
generated through combining an orthogonal cascade with a linear cascade allowing for regeneration 
of a co-substrate though downstream processing of an intermediate from the initial enzyme reaction 
(Figure 1F [37]). This ultimately reduces input of co-substrate required, as well as driving the 
equilibria forward for the successive reaction and has been referred to a ‘recycling’ cascade  [38]. The 
critical examples below (3.1/3.2) illustrate practical combinations of cascades. 
 
2.2 Advantages and disadvantages of cascade reactions 
There is a broad desire to carry out multiple chemical steps in a single reaction process. Where this is 
successful, it reduces challenges of intermediate stability, isolation/purification of desired 
compounds, and solvent exchange [6]. There are obvious benefits in terms of space and resource 
use, and often the time taken to complete a process [3]. Whilst there are many good examples of 
chemical “one-pot” syntheses that combine two or more steps, in the majority of cases , 
incompatibility of conditions (especially solvents, pH and co-catalysts) requires reactions to be 













Cascading reactions facilitated by multiple enzymes have the potential to overcome many of the 
challenges within synthetic or semi-synthetic chemistry [15]. As enzymes generally have compatible 
reaction conditions (neutral or slightly alkaline pH, mild temperature, presence of similar salts and 
mild reducing agents) [39], there are reduced barriers to having multiple reactions proceeding 
simultaneously in comparison to purely chemical reactions. For enzyme-catalysed reactions, this 
offers particular advantages. Enzyme reactions can generate partially unstable intermediates, and a 
cascade reaction can resolve this with a further reaction [40]. This has the particular advantage of 
facilitating schemes including reactive substrates (e.g. aldehydes). Enzymes catalyse both forward 
and reverse reactions, and so reactions operating closer to equilibrium result in a mix ture of 
substrate and product. Using enzyme cascades offers the opportunity to drive reactions towards 
completion by coupling with another reaction to drive the reaction in the desired direction [18]. Side 
reactions are also minimised in cascade reactions, as successive reactions drive equilibria in favour of 
the desired product. 
However, the disadvantages of enzyme cascades must be considered when designing new 
biotransformations. In particular, the majority of enzymes have a narrow operational range, and 
precise requirements for activity [39]. Enzymes generally show greater than 50% activity over a pH 
window of 2-5 pH units; enzyme activity generally increases with temperature until the protein 
unfolds; and enzymes require a collection of salts and buffers that may not be compatible ( e.g. 
magnesium is both a cofactor and inhibitor of many enzymes). Particularly where enzymes in the 
cascade have differing cofactor requirements, cascades may require multi-factorial optimisation (e.g. 
using a design of experiments approach [41]) to obtain maximum activity. 
A further challenge for incorporation of enzyme cascades into larger synthetic pipelines is that 
enzymes are generally evolutionarily optimised towards their biological role in vivo, rather than large 
scale industrial application. Challenges imposed by this include poor solvent compatibility with 
desired products [42], restricted substrate ranges [39], substrate flux sinks [43], and low turnover 
rates.  Initially many enzymes were only available in small amounts and at high cost, being extracted 
from animal or plant tissues [8]. With developments of molecular biology techniques and discovery 
of new enzymes using bioinformatics it is possible to produce many enzymes in the quantities 
required for industrial applications. A limitation is still often encountered in enzyme expression in a 
soluble form and enzyme stability. However, this is improving with the development of new 
expression vectors and expression hosts allowing enzymatic applications for in vitro processes. These 
limitations apply not only to enzyme cascades but also chemoenzymatic cascades [26], primarily due 
to reaction condition incompatibility [44]. However, several examples of incorporation of chemical 














2.3 Cofactor recycling 
Many enzyme-catalysed transformations require cofactors. These are complex organic molecules 
that assist the protein with catalytic activity, facilitating reactions that are challenging using only the 
twenty natural amino acids [39]. In many cases these are catalytic and are required only at a 
concentration sufficient to ensure complete loading of enzymes (e.g. thiamine diphosphate, 
pyridoxal phosphate). However, the most common enzyme cofactors, NAD+, NADP+ and ATP, form 
part of the reaction and are modified as well as the substrates (e.g. NAD+ accepts a hydride as a 
substrate is oxidised). These coenzymes are too costly to provide at stoichiometric levels [29], and 
are easily degraded under some conditions, for example the presence of oxygen presence, extremes 
of pH or high temperature [49]. This can be a problem for enzyme cascades comprising enzymes 
requiring cofactors and prevents their more widespread use in industry. For a biotransformation to 
be economically viable an efficient regeneration and reuse of the cofactors is essential [50]. The field 
of co-factor recycling has been extensively studied for oxidoreductases as the enzymes in this class 
require the NAD(H) or NADP(H) cofactors. Many chemical, enzymatic and electrochemical methods 
have been investigated to regenerate various cofactors [51, 52]. There are two main strategies for 
enzymatic cofactor regeneration. The first approach is a substrate-coupled reaction systems, in 
which one enzyme that uses both the reduced and oxidized forms of a cofactor is applied to catalyse 
both the synthesis of the product from one substrate and the cofactor regeneration reaction with a 
second substrate [50]. An example of substrate coupled regeneration is described by Tan and co-
workers [53] using Streptomyces griseus carbonyl reductase for the conversion of prochiral ketones 
into highly optically active alcohols. Isopropanol was used as the co-substrate for the NADH recycling 
in the substrate-coupled reaction (Figure 2A).  
The second strategy, enzyme-coupled reactions, makes use of a different enzyme to catalyse the 
cofactor regeneration reaction. This strategy provides much greater flexibility in term of choice of 
substrates and is widely used. For example, the most commonly used recycling enzymes for NADH 
and NADPH are glucose or formate dehydrogenases [54]. More recently, the P450 BM3 
monooxygenase has been used to regenerate NADP+ through the direct reduction of oxygen (Figure 
2B; [55]). Also, excellent total turnover numbers have been achieved using a glutathione-based 
recycling system that combines glutaredoxin from Escherichia coli and the glutathione reductase 
from Saccharomyces cerevisiae for NADP+ regeneration. This system uses organic disulfides (oxidized 













turnover number in excess of 5 × 105 [56]. Phosphite dehydrogenases have also been employed, 
which offer the advantages of an inexpensive substrate and unreactive product (phosphate) [57]. 
ATP regeneration is less studied than other cofactor regeneration systems. In recent years several 
methods have emerged using enzymes like pyruvate kinase, creatine kinase, adenylate kinase and 
polyphosphate kinase [52, 58]. More recently, the use of E. coli cell lysate was shown to be an 
effective way to recycle ATP [59]. This method used the acetate kinase activity in the lysate to 
simultaneously support multiple ATP-dependent enzyme-catalysed chemical processes. The 
equilibrium was driven towards ATP recycling by the addition of cheap acetyl phosphate.   
 
2.4 Kinetic modelling of cascades 
A major challenge for the deployment of biocatalytic processes to industrial process plants is to 
determine the appropriate and optimal scales for operation, and the quantities of each reactant to 
be used. Developing a reaction model early in the design process can demonstrate the practical and 
economic feasibility of a proposed process [60]. Models can further aid the critical evaluation of 
pathways and highlight potential issues (e.g. bottlenecks, inhibitors, side-product formation) [61, 
62]. However, such reaction engineering is a particular concern for enzyme cascades, as the detailed 
modelling of even a single enzymatic process can be challenging [41]. The two main approaches to 
modelling cascades are constraint-based modelling and kinetic modelling. Constraint-based 
modelling abstracts the process into mathematical equations (e.g. flux-balance analysis, or a design 
of experiments approach [63, 64]). Parameters are fitted to these equations based on experimental 
measurement of the system. These models have the advantages of making no assumptions about 
the system, and being experimentally efficient. However, the abstract nature of these models 
renders them less able to predict or identify bottlenecks [60]. 
Kinetic models, in contrast, are based on kinetic rate laws for individual reactions. The relevant rate 
laws and parameters for each step are determined experimentally, using either a systematic 
approach [65, 66] or a design of experiments approach [41]. Alternatively, parameters have been 
fitted to the entire system for up to fifteen reactions [67]. The large number of parameters to be 
fitted leads to multiple solutions, reducing the predictive power of the model  [67]. Kinetic models 
have proved highly insightful in the study of metabolic pathways in well -studied model organisms 
[68, 69]. However, the use of kinetic modelling has been poorly utilised or ignored in most process 
development. Indeed, kinetic models of enzymatic reactions have only been explored in a few 













system for synthesis of 6-hydroxyhexanoic acid [70], modelling of the stability of an aldolase [71], or 
a three-enzyme cascade for the biotransformation of sucrose to cellobiose  [72]. 
Both constraint-based and kinetic modelling have pitfalls that must be considered for application to 
industrial processes. In particular, industrial processes usually require high concentrations of 
reactants to be economic [41], and non-aqueous solvents are likely to be necessary to maintain 
substrates, products and intermediates at these concentrations. The conditions modelled may not 
be reflective of the final process. This is particularly the case for kinetic models, as the detailed 
parameters may well be affected by these conditions, and other reactants become inhibitory at the 
high concentrations.  
 
3. Critical examples 
3.1 Transaminase cascades 
Transaminases (TAs; EC 2.6.1) are enzymes whose use in the industrial biocatalysis pipeline is mature 
[73, 74]. Since many drugs have chiral amines within their structures the TAs have been used 
extensively by pharmaceutical companies to provide these important building blocks (Figure 3A). 
The TAs are part of a large group of enzymes that use the pyridoxal phosphate cofactor (PLP). This 
forms a covalent bond (a Schiff base) with the N atom of the active site lysine during the reaction 
mechanism [75]. The TA family of enzymes have been classified into six different Pfam groups on the 
basis of their secondary/ternary structure and substrate specificities [76]. The TAs most commonly 
used in biocatalysis are the TA group 3 enzymes. These are the so-called ω-TAs that catalyse the 
amination of substrates with a ketone/aldehyde component distal to the carboxyl group [77]. These 
TAs generally have a broad substrate specificity, and are all (S)-selective. Key examples are the TAs 
from Vibrio fluvialis [78], Chromobacterium violaceus and Pseudomonas aeruginosa [79], all of which 
have been biochemically and structurally characterised [80-82]. There are many examples where 
these TAs have been employed in cascade reactions to produce chiral amines by both kinetic 
resolution via enantioselective deamination or by asymmetric synthesis using reductive amination 
(reviewed by [29, 75]). The reductive amination allows the product to be produced in 100% yield. 
However, there is an unfavourable equilibrium which lies on the side of the starting material. An 
early approach utilised other enzymes such as a lactate dehydrogenase coupled to glucose 
dehydrogenase to shift the equilibrium to product formation [83, 84]. Related approaches use 
pyruvate decarboxylase [85]. The essential PLP cofactor can potentially be recycled in situ on the 













PLP needs to be present in the biocatalytic reaction [86].   For these reasons and to enable to control 
the flux through the enzyme cascade these reactions are carried out in vitro. The linking enzymes 
that drive the equilibrium to completion were used together as part of a larger cascade by Pickl and 
colleagues to prepare a series of functionalised amines from the corresponding alcohols (Figure 3B) 
[87], and by Monti and colleagues to prepare functionalised amines from unsaturated ketones [88].  
The group 4 TAs have also been of specific interest since they catalyse transamination of branched 
chain L-amino acids (BCAAs), D-amino acids or ω-amino acids. These enzymes are naturally (R) 
selective and the catalysis within this group occurs on the re-side of the cofactor, which differs from 
most of the other PLP enzymes where the reactions occur on the si-side. By comparing the sequence 
for group 4 TAs activity a sequence fingerprint has been established [89]. In addition to the 
commercially available enzymes, many groups have modified TA enzymes using rational and semi-
rational protein engineering and directed evolution methods [90]. More thermally stable and robust 
TA enzymes of the groups 3 and 4 have been identi fied and characterised from thermophilic 
genomes and metagenomes [91, 92]. 
An industrial milestone for using the (R) selective enzymes was achieved by Merck and Codexis who 
applied an engineered TA for the large scale biocatalytic production of the Sitagliptin, an important 
anti-hypertensive drug [93]. Many new cascade reactions have been developed using the TA 
enzymes and this mini-review can only provide a few examples. These cascades involve other 
enzymes to access biocatalytic routes to an increasing number of biologically active important 
compounds. TAs have been used in combination with monoamine oxidase variants to enable the 
regio- and stereo-selective synthesis of chiral 2,5-disubstituted pyrrolidine building blocks and the 
deracemization and dealkylation of a range of methylbenzylamine derivatives (Figure 3C) [28, 94]. 
Another elegant example of the advantages of TAs is the synthesis of the vasopressor methoxamine 
from 2,5-dimethoxybenzaldehyde and pyruvate [95]. The product, generated from two achiral 
substrates, contains two newly formed chiral centres. With careful selection of the enzymes, the 
preferred stereoisomer was over 99% of the product, with a yield of 64% (Figure 3D). A similar 
approach extended the cascade with norcoclaurine synthase to convert the product to form 
industrially valuable tetrahydroisoquinolines (Figure 3E [44]). These reactions were most efficient 
when performed sequentially without purification of intermediates, to prevent the enzymes forming 
side products or catalysing unwanted reactions. This highlights one of the challenges of extending 














An interesting cascade reaction using an ω-TA together with the following highlighted enzymes 
(carboxylic acid reductases) together with an imine reductase enzyme has been used in a one pot 
synthesis of mono and di-substituted piperidines and pyrrolidines, which are found in many 
biologically active natural products and pharmaceuticals [96]. This further illustrates how the 
application of the TA enzymes has been vital to accelerate the reduction of traditional chemistry by 
more sustainable biocatalytic reactions.  
 
3.2 Carboxylic acid reductase cascades 
Carboxylic acid reductases (CARs; EC 1.2.1.30) are a family of enzymes with increasing importance in 
‘green’ chemistry [97, 98]. They are large (~130 kDa) multi-domain enzymes that catalyse the 
reduction of both aromatic and aliphatic carboxylic acids to their aldehydes [40, 99]. This 
thermodynamically unfavourable reaction is driven by the hydrolysis of ATP to AMP and 
pyrophosphate, and the oxidation of NADPH to NADP+ [40]. CARs offer an environmentally attractive 
alternative to the use of harsh reducing agents such as LiAlH4. Their regioselective reduction of 
carboxylic groups eliminates the need for protection, and they operate under mild conditions. CARs 
are particularly attractive for cascade reactions, as they generate the reactive aldehyde group in a 
single step (avoiding the full reduction and selective oxidation often necessary with chemical 
methods). This group is a substrate for a wide range of synthetically useful reactions  (for example 
reductive aminases [100]), whilst many chemical and enzymatic reactions produce carboxylic acid 
moieties (Figure 4A; [65, 98, 100]). In vivo pathways using CARs to connect reactions have been 
successfully achieved. Examples include the production of the flavour vanillin by yeast [101], the 
drug building block 3-hydroxytyrosol [102] and a synthetic pathway for the production of propane in 
E. coli [103].  
An elegant example of a cascade reaction to exploit CARs was demonstrated by France et al. [96]. 
They employed a three enzyme cascade (CAR, transaminase - TA, imine reductase - IRED) to convert 
keto acids into piperidines (Figure 4B), which are common pharmaceutical building blocks. The final 
step in this cascade creates a new stereocentre, and substrates can have additional chirality. The 
product enantiomers depend on the choice of stereoselective TAs and IREDs. This work also included 
an orthogonal cascade, using lactate dehydrogenase to remove the TA product pyruvate and so 
drive the intermediate step to completion. One limitation of this cascade is the need for two 
reducing equivalents per reaction. To overcome this, the same team successfully added the main 
cascade for expression in E. coli (which has abundant lactate dehydrogenase) [104]. They achieved 
conversion rates of up to 93% for a three step in vivo transformation. This demonstrates the concept 













cofactor requirements and synthesise enzymes. The cells can then produce pharmaceutically and 
industrially relevant chemical scaffolds. 
An alternative approach to the industrial application of CARs is to utilise recycling cascades to 
regenerate cofactors in vitro. Strohmeier et al. [105] used two parallel recycling cascades to 
regenerate the ATP and NADPH cofactors of CARs (Figure 4C). They used the commonly employed 
polyphosphate kinase pathway to regenerate ATP, and glucose dehydrogenase to regenerate 
NADPH. Using these recycling cascades, a range of aliphatic and aromatic carboxylic acids were 
converted to aldehydes with over 99% conversion, when using ATP and NADPH at a 1:10 and 1:20 
ratio with respect to the substrate. 
Finnigan et al. combined these two ideas to develop a three step enzymatic cascade from an ester to 
an alcohol in vitro [65]. This transformation included two parallel recycling cascades and an 
orthogonal cascade to remove an inhibitory by-product, requiring seven enzymes (Figure 4D). This 
cascade was demonstrated for the reduction of methyl 4-toluate to 4-tolyl alcohol, and achieved 
approximately 75% yield of product. This study developed and validated a kinetic model of the entire 
seven enzyme system, and demonstrated that this could be used to optimise conditions for 
increased turnover. This work highlights the value of kinetic models for developing enzymatic 
cascades, and that this is eminently possible for systems even with complex cascades.  
 
4. Conclusions and perspective  
Biocatalysis has a proven track record of offering replacements for individual chemical reactions with 
a lower environmental impact. Cascade reactions are an extension of biocatalysis to couple a series 
of reactions and so provide replacement for more than one chemical step. Cascade reactions offer 
several further advantages in comparison to conventional biocatalysis. In particular, they provide a 
route to utilising enzymes that operate near equilibrium, or which have unstable substrates or 
products. Effective recycling cascades have been developed to recover costly cofactors using  
inexpensive sacrifice substrates. Modelling approaches are being developed to predict conditions for 
optimal turnover, especially at the high concentrations that are required for economic scale -up. The 
carboxylic acid reductases are an important example of enzymes that have been successfully 
deployed in vivo, and which are now being developed for biocatalytic cascades. They demonstrate 
the advantages of using cascades by linking reactions and providing a highly reactive product 
utilising the development of cofactor recycling cascades. Transaminases demonstrate the value of 













different partner enzymes highlights the value of “modular” enzyme sets. Successful industrial 
deployment of cascade reactions illustrates their rich potential as part of the industrial synthetic 
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Figure 1. Types of enzyme cascade. A: Linear cascade: a single product is synthesized via one or 
more intermediates states from an initial substrate. B: Cyclic cascade: a combination of substrates is 
transformed into an intermediate that is subsequently converted back to substrate, shifting the 
equilibrium towards one of the initial substrates. C: Orthogonal cascade: product formation is 
coupled with a co-factor/co-substrate regeneration step or to destructive by-product reactions. D: 
Parallel cascade: two distinct enzymatic reactions are coupled through co-factors/co-substrates. E & 
F: Combinations: these enzymatic cascades can be combined to produce novel cascades . For 

















Figure 2: Examples of substrate and enzyme coupled cofactor regeneration strategy. A: Conversion 
of 4-chloro-3-oxobutanoate (COBE) to (S)-4-chloro-3-hydroxybutanoate ((S)CHBE) via Streptomyces 
griseus carbonyl reductase (SgCR), the recycling of NADH is an example of substrate coupled 
conversion with 1.6 equivalent of isopropanol to COBE [53]. B: The Thermoanaerobacter brockii 
alcohol dehydrogenase (TbADH) catalyses the conversion of the racemic alcohol 1-nonen-4-ol to (S)-
1-nonen-4-ol and the corresponding ketone. The reaction is coupled to P450 BM3 for NADP + 
regeneration. Surprisingly, the P450 BM3 cofactor regeneration enzyme can uncouple from its usual 
















Figure 3. Utilizing transaminases in multi-step enzyme reactions. A: TA can use products from many 













enzymes. Cofactors and additional substrates are not shown for clarity. AcT: acetyltransferase [106]; 
ADH: alcohol dehydrogenase; AmDH: amine dehydrogenase; CAR: carboxylic acid reductase; MAO: 
monoamine oxidase; TA: transaminase. B: Transaminase based cascade to aminate primary alcohols. 
Several auxiliary enzymes drive this reaction to completion through by-product and cofactor 
recycling mechanisms utilizing HRP/catalase, AlanineDH and GDH. AO: Alcohol Oxidase, HRP: Horse 
radish peroxidase, AlanineDH: Alanine dehydrogenase, GDH: Glucose dehydrogenase. [67] C: Chiral 
2,5-disubstituted pyrrolidine building blocks were synthesised using a chemoenzymatic cascade. This 
approach exploits several biocatalytic processes and takes advantage of the complementary 
regioselectivity displayed by the ω‐TA and MAO variants to establish two stereogenic  centres, 
minimising waste generation. LDH: Lactate dehydrogenase. [28, 94] D: (1S,2R)-methoxamine 
synthesis using a biocatalytic 1-pot two-step cascade approach. PDC: pyruvate decarboxylase. [95] E: 
Example of a enzymatic and chemoenzymatic three‐step cascade for the synthesis of the 
trisubstituted tetrahydroisoquinoline (1S,3S,4R)‐1‐(2‐bromophenyl)‐1,2,3,4‐tetrahydroisoquinoline‐
















Figure 4. Utilizing CARs in multi-step enzyme reactions. A: CARs join many industrially relevant 
enzyme reactions, making them useful for the construction of novel multi -step enzyme reactions. 













alcohol dehydrogenase, TA: transaminase, IRED: imine reductase, AmDH: amine dehydrogenase, 
CAR: carboxylic acid reductase. [65, 96, 107, 108] B: Whole cell de novo enzyme cascade for the 
diastereoselective and/or enantioselective conversion of linear keto acids into cyclic amine products. 
This cascade proceeds through carboxylic acid reduction, transamination, imine formation, and 
imine reduction. The cascade required a keto acid substrate and an amine donor. TA: Transaminase, 
(R/S)-IRED: imine reductase, LDH: lactate dehydrogenase. The TA cofactor pyridoxal -5′-phosphate is 
not shown. [96] C: Reaction Scheme for the in vitro reduction of carboxylic acids with full recycling of 
all cofactors. PPK: polyphosphate kinase, GDH: glucose dehydrogenase, Pn: polyphosphate, PPi: 
pyrophosphate, PPiase: pyrophosphatase, PO4: phosphate. [105] D: A modelled seven enzyme 
reaction for the production of 4‐tolylalcohol from methyl 4‐toluate via the intermediates 4‐toluic 
acid and 4‐tolualdehyde. EST: Esterase, ADH: Alcohol dehydrogenase, PTDH: phosphite 
dehydrogenase, PAP: Polyphosphate AMP phosphotransferase, AK: Adenylate kinase, PO3: 
Phosphite. R: R-group, limited by enzyme substrate specificity. For clarity, phosphopantetheinyl 
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